Self-tonometry with the iCare® Home2 and a smartphone app is feasible in motivated patients with glaucoma, a study shows.
The FDA has extended the review period for the BLA for NT-501 in the treatment of macular telangiectasia type 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback